Replies to post #58808 on NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

I disagree with your other point because you are not accounting for the stable disease inflammation in the main group, you are not accounting for the pseudo progression arm of 32 and there were only two confirmed classical in the group Dr. Prins subtyped. One lived over 50 months if I recall. --flipper

Okay so "stable disease inflammation" is what exactly? Just coined a new phrase right dere? TM flipper 2016?

I won't be redundant, there's no point. Anyone that wants to look at data objectively can search through my and AVII's posts on this topic. It's OBVIOUS by all accounts the long tail in the two small UCLA studies used to promote the vaccine used in the current P3 on clinical hold (even though both studies used diff tech than each other and also different tech than what is used in the current trial, which has been ON HOLD for over 8 months now) were psPD patients. There are however any number of ways to delude yourselves into believing anything at all that you desire.

This is just more proof that human behavior is pattern specific. Only the names change. You're playing your part, but it's not a valiant one.

[flipper44]

Also, I think your 2x for psPd with SOC is high. Regardless, I expect the 32 arm to blow well beyond that. IMHO it will be looking more like a cure in the majority of those patients. -- using 5 years as an initial threshold.